FIELD: chemistry.
SUBSTANCE: invention is aimed at dipyrazole compounds of formula I and their pharmaceutically acceptable salts, where radicals and groups are defined in claim 1 of the formula of invention. Disclosed compounds modulate AMPA and NMDA receptor functioning. A pharmaceutical composition based on formula I compounds and separate dipyrazole compounds are also part of the subject of invention.
EFFECT: possibility of using compounds as pharmaceutical agents, mainly for treating psychoneurological diseases.
16 cl, 2 tbl, 39 ex
Title | Year | Author | Number |
---|---|---|---|
(3-CYCLOALKYL-2, 3, 4, 5 - TETRAHYDRO-1H-BENZO [d] AZEPIN-7-YLOXY) DERIVATIVES, USE THEREOF FOR INHIBITING H3 RECEPTORS, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD | 2003 |
|
RU2388752C2 |
NEW COMPOUNDS AS MODULATOR OF OPIOTIC RECEPTORS | 2003 |
|
RU2332411C2 |
TETRACYCLIC COMPOUNDS | 2010 |
|
RU2585622C2 |
TETRACYCLIC COMPOUNDS | 2010 |
|
RU2725140C2 |
PRIMARY AMINE DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES | 2012 |
|
RU2596867C2 |
1,3,4-OXADIAZOL-2-ONS AS PPAR-DELTA MODULATORS, BASED ON THEM PHARMACEUTICAL COMPOSITIONS AND METHOD OF TREATMENT | 2005 |
|
RU2365589C2 |
TRIAZOLIUM SALT AS RAR1 INHIBITORS, PREPARING THEM AND USING AS DRUG PREPARATION | 2009 |
|
RU2494100C2 |
METHOD OF PRODUCING 1,4-DIPHENYLAZETIDINONE DERIVATIVES | 2005 |
|
RU2380361C2 |
SPLICEOSTATIN ANALOGS | 2013 |
|
RU2618523C2 |
NOCICEPTIN ANALOGUES | 2002 |
|
RU2426730C2 |
Authors
Dates
2010-10-10—Published
2006-03-15—Filed